John B. Green
2019
In 2019, John B. Green earned a total compensation of $2.1M as Chief Financial Officer at Dicerna Pharmaceuticals, a 67% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $200,855 |
|---|---|
| Option Awards | $1,465,200 |
| Salary | $401,709 |
| Other | $18,858 |
| Total | $2,086,622 |
Green received $1.5M in option awards, accounting for 70% of the total pay in 2019.
Green also received $200.9K in non-equity incentive plan, $401.7K in salary and $18.9K in other compensation.
Rankings
In 2019, John B. Green's compensation ranked 5,717th out of 13,971 executives tracked by ExecPay. In other words, Green earned more than 59.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,717 out of 13,971 | 59th |
Division Manufacturing | 2,140 out of 5,701 | 63rd |
Major group Chemicals And Allied Products | 770 out of 2,200 | 65th |
Industry group Drugs | 647 out of 1,886 | 66th |
Industry Pharmaceutical Preparations | 474 out of 1,398 | 66th |
Source: SEC filing on April 22, 2020.
Green's colleagues
We found four more compensation records of executives who worked with John B. Green at Dicerna Pharmaceuticals in 2019.